|
US2009137658A1
|
|
Benzenesulfonic acid salt compounds
|
|
US2008027037A1
|
|
Cyclic compounds
|
|
US2008027014A1
|
|
Novel SGLT inhibitors
|
|
TW200808731A
|
|
A process for preparing tetrahydroquinoline derivatives
|
|
JP2007277231A
|
|
Pharmaceutical composition
|
|
JP2007277230A
|
|
Pharmaceutical composition
|
|
JP2007277224A
|
|
Method for producing trans-4-amino-1-methylcyclohexanols
|
|
JP2007217408A
|
|
Pharmaceutical composition
|
|
JP2007217407A
|
|
Pharmaceutical composition
|
|
JP2007197428A
|
|
Pharmaceutical composition
|
|
WO2007063935A1
|
|
Aromatic compound
|
|
WO2007063934A1
|
|
Alicyclic heterocyclic compound
|
|
JP2007176933A
|
|
Medicinal composition
|
|
JP2007169270A
|
|
Medicinal composition
|
|
JP2007145819A
|
|
Pharmaceutical composition
|
|
WO2007046550A1
|
|
Pyrazole compounds having cannabinoid receptor (cb1) antagonizing activity
|
|
WO2007040238A1
|
|
Process for production of optically active 4-hydroxy-1,2,3,4 -tetrahydroquinolines
|
|
JP2007119451A
|
|
Pharmaceutical composition
|
|
JP2007119450A
|
|
Pharmaceutical composition
|
|
TW200740782A
|
|
Thiomorpholine compound and process for preparing the same
|
